Tagged with Africa

Tunisia Lasaâd Boujbel, CEO of MédiS Group, and founder of the company, today leads what became one of the first Tunisian-based multinationals. His company’s recent investments in the Tunisian headquarters and in Senegal respectively respond to increased international demand and desires of expansion in the African market. MédiS has built up…

Pharma The following statistics provide an overview of South Africa’s healthcare environment, including population, life expectancy, ten leading causes of death, and healthcare expenditure. Click here to read more articles and interviews from South Africa, and to download the latest free pharma report on the country.  

Pharma The following chart shows the top 10 corporation in the South African pharma market. Domestic champions Aspen and Adcock Ingram lead the way in terms of market share and most of the top 10 are growing well above the market average. Click here to read more articles and interviews from…

Pharma The following chart shows the prevalence of HIV and AIDS in South Africa; a country where 6.3 million people are living with HIV and in which there are 200,000 AIDS-related deaths per year. Click here to read more articles and interviews from South Africa, and to download the latest free…

South Africa Trailing behind South Africa’s pharmaceutical market in both value and growth, the nation’s medical device industry has long enjoyed minimal barriers to entry and easy market access. But, with imminent onset of a new regulatory regime, both local and multinational players of all sizes may have to start imposing stricter…

Pharma Eclectic demographics, rapid patient recruitment, and a burgeoning population with a gradient of disease profiles—these seem to be the fundamentals truly driving growth in South Africa’s clinical trial industry. However, without the presence of proper mechanisms to arbitrate between regulators and researchers, the sustained growth of this industry may very…

Pharma While South Africa faces a distinct set of challenges in effectively managing its healthcare sector, the ecosystem for innovation, particularly in the world of biotechnology remains fruitful. Bioentrepreneur Nick Duneas has taken the initiative to create his own startup and introduce the world’s first regenerating injectable bone-graph substitute into the…

Pharma Fresenius Kabi’s general manager for the MENA region discusses evolving attitudes towards clinical nutrition for critically ill patients and Egypt’s positioning as a knowledge center and source of medical professionals at the regional level. Fresenius is the undisputed provider of critical care worldwide. What products do you offer in Egypt…

Pharma Japanese company Otsuka envisioned Egypt as a hub for its Middle East and African operations as early as 1995. The president of the local subsidiary discusses the current activities of the company as well as its plans to leverage Egypt to penetrate further into the region. Last year, Otsuka chose…

Pharma Pharmaceuticals Mauritius’s economic stability, genetic diversity, cost competitiveness, and location make it a perfect location for clinical research; a fact the state is now actively promoting. A further vision of the Mauritian government is to transform the island into a medical hub for clinical research. Besides political and economic stability, a number of…

Pharma While growth forecasts for the MENA region remain high, falling oil prices and political instability are creating significant government budgetary challenges for the industry to adapt to. Janssen’s area managing director Khaled Mansour explains how the pharmaceutical industry can work to support Middle Eastern healthcare systems during this challenging period…

Pharma “My primary concern is not the current economic situation, but rather the fact that there does not appear to be a clear vision for how Egypt can overcome these challenges and set the economy on a stronger growth trajectory,” says October Pharma CEO Ahmed Zaghloul You were last interviewed by…